Mixtard 30 Flexpen (Insulin Human)

Insulin human, the active ingredient in Mixtard 30 Flexpen, is an insulin presented as a solution for subcutaneous injection pen device for subcutaneous use. It treats hyperglycemia in patients with diabetes mellitus, including both type 1 and type 2 disease.

GNH USA supplies Mixtard 30 Flexpen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mixtard 30 Flexpen is an insulin preparation used in the management of diabetes mellitus, a disorder of glucose regulation.

Type 1 diabetes mellitus: provides basal and prandial insulin to achieve glycemic control. Type 2 diabetes mellitus: supplements endogenous insulin to lower elevated blood glucose levels. Insulin deficiency: replaces missing hormone to maintain normal metabolism. Post‑prandial hyperglycemia: smoothes glucose spikes after meals. Hyperglycemia: reduces overall blood glucose concentrations.

Insulin human may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Hypoglycemia: low blood sugar episodes, especially if meals are missed or dose is excessive. - Injection site reactions: redness, swelling, or itching at the injection site. - Weight gain: increased appetite and caloric storage. - Edema: mild fluid retention, particularly in the lower extremities.

Serious or Rare Side Effects: - Severe hypoglycemia leading to seizures or loss of consciousness. - Anaphylactic or severe allergic reactions, including rash, bronchospasm, or angioedema. - Development of insulin antibodies that may alter drug efficacy.

When using Mixtard 30 Flexpen, several safety considerations should be observed.

Hypoglycemia risk: monitor blood glucose and adjust dose as needed. Renal impairment: consider dose reduction and close monitoring. Pregnancy: use only if benefits outweigh risks and under medical supervision. Allergic reactions: discontinue if signs of hypersensitivity appear. Injection site rotation: avoid repeated use in same area to prevent lipodystrophy. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Mixtard 30 Flexpen can interact with other medicines, affecting glucose control.

Major Interactions (Avoid): - Sulfonylureas: combined use may precipitate severe hypoglycemia. - Beta‑blockers: can mask hypoglycemia symptoms, requiring careful monitoring. - Alcohol: may potentiate insulin’s glucose‑lowering effect, increasing hypoglycemia risk.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: may raise blood glucose, necessitating dose adjustment. - Corticosteroids: can increase insulin requirements, requiring close observation. - ACE inhibitors: may enhance insulin sensitivity, potentially leading to lower glucose levels.